Hutchison MediPharma is a leading biotechnology company in China. It was founded in Shanghai’s Zhangjiang High Tech Park in September 2002. Since then, the company has built one of the largest and most experienced new drug R&D teams in China with over hundreds employees, of whom more than 80% have masters degrees and above. It is led by a first class senior management team, all of whom have many years of experience succeeding at large US pharmaceutical and biotech companies. Hutchison MediPharma is dedicated to bringing innovative therapies to the global market and focuses on the therapeutic area of autoimmune diseases and oncology. Combining world-class R&D expertise and technologies with China resources, Hutchison MediPharma has established a unique portfolio of high quality preclinical and clinical candidates.
和记黄埔医药（上海）有限公司（和记黄埔医药）是一家领先的中国新药研发企业，位于中国上海张江高科技园区。公司成立于2002年9月，自成立来，和记黄埔医药茁壮成长，发展成为中国新药研发领域的领军企业。和记黄埔医药拥有中国最大，最有经验的创新药物研发团队之一。目前公司共有数百名研发人员，80%以上为硕士及以上学历。公司的高级管理层均来自美国大型制药公司，拥有丰富的全球创新药物研发经验。以中国丰富研发资源为依托，和记黄埔医药致力于为全球市场研发创新药物。公司主要研发治疗癌症和自身免疫性疾病的创新药物。和记黄埔医药将世界一流的研发经验、技术平台与中国的资源相结合，开发了一系列高质量的临床前和进入临床研究阶段的具有自主知识产权的创新药物。
Lu-E shares the innovation with you.
Lu-E与您一起分享。
